MedPath

Evaluation of the therapeutic effect of fluconazol drop on chronic rhinosinusitis

Not Applicable
Conditions
(B95-B97)
rhinosinusitis.
Bacterial, viral and other infectious agents
Registration Number
IRCT138811063186N1
Lead Sponsor
Hamedan University of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
54
Inclusion Criteria

the patients with diagnosis of chronic rhinosinusitis according to American Academy of Otolaryngology which have no response to medical therapy;
Exclusion criteria: known sensitivity to fluconazole; pregnancy and breast feeding women; immune compromised patients; patients with acute complication of CRS; superimposition of ARS(fever, acute pain, pressure on face); antibiotic use in recent 7 days ; age below 18 years; systemic antifungal use in recent 7 days and systemic steroid use in recent 30 days

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Snot-20. Timepoint: 2 months. Method of measurement: Check list.;CT score. Timepoint: 2 months. Method of measurement: Check list.
Secondary Outcome Measures
NameTimeMethod
Side effect. Timepoint: 2 months. Method of measurement: Check list.
© Copyright 2025. All Rights Reserved by MedPath